Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-18

Clinical Trial Update: Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study investigating whether neuraminidase activity contributes to endothelial dysfunction in type 2 diabetes, with the trial results now posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2025-04-18